Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor
Autor: | Jenny A Paniagua-Padilla, Lucina Bobadilla-Morales, Alfredo Corona-Rivera, Citlalli Ortega-de-la-Torre, Helia Judith Pimentel-Gutiérrez, Oscar Gonzalez-Ramella, Sergio Gallegos-Castorena, Rocío Silva-Cruz, Abraham Zepeda-Moreno, Fernando Sánchez-Zubieta, Jorge Román Corona-Rivera |
---|---|
Rok vydání: | 2015 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment Case Report Chromosomal translocation Hematopoietic stem cell transplantation Y chromosome Biochemistry Genetics medicine Genetics(clinical) Molecular Biology Genetics (clinical) Biochemistry medical Acute myeloid leukemia business.industry Biochemistry (medical) Cytogenetics Myeloid leukemia Donor cell leukemia Karyotype medicine.disease Molecular medicine Leukemia Allogeneic hematopoietic stem cell transplantation Immunology Molecular Medicine business |
Zdroj: | Molecular Cytogenetics |
ISSN: | 1755-8166 |
DOI: | 10.1186/s13039-014-0105-4 |
Popis: | Here we present a male patient with acute myeloid leukemia (AML) initially diagnosed as M5 and with karyotype 46,XY. After induction therapy, he underwent a HLA-matched allogeneic hematopoietic stem cell transplantation, and six years later he relapsed as AML M1 with an abnormal karyotype //47,XX,+10[2]/47,XX,+11[3]/48,XX,+10,+11[2]/46,XX[13]. Based on this, we tested the possibility of donor cell origin by FISH and molecular STR analysis. We found no evidence of Y chromosome presence by FISH and STR analysis consistent with the success of the allogeneic hematopoietic stem cell transplantation from the female donor. FISH studies confirmed trisomies and no evidence of MLL translocation either p53 or ATM deletion. Additionally 28 fusion common leukemia transcripts were evaluated by multiplex reverse transcriptase-polymerase chain reaction assay and were not rearranged. STR analysis showed a complete donor chimerism. Thus, donor cell leukemia (DCL) was concluded, being essential the use of cytological and molecular approaches. Pediatric DCL is uncommon, our patient seems to be the sixth case and additionally it presented a late donor cell leukemia appearance. Different extrinsic and intrinsic mechanisms have been considered to explain this uncommon finding as well as the implications to the patient. |
Databáze: | OpenAIRE |
Externí odkaz: |